Cargando…

Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines

Several approaches have been developed to improve or replace the only available vaccine for tuberculosis (TB), BCG (Bacille Calmette Guerin). The development of subunit protein vaccines is a promising strategy because it combines specificity and safety. In addition, subunit protein vaccines can be d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Junqueira-Kipnis, Ana Paula, Marques Neto, Lázaro Moreira, Kipnis, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005953/ https://www.ncbi.nlm.nih.gov/pubmed/24795730 http://dx.doi.org/10.3389/fimmu.2014.00188

Ejemplares similares

Live Vaccines Have Different NK Cells and Neutrophils Requirements for the Development of a Protective Immune Response Against Tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2020)

Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
por: Marques Neto, Lázaro Moreira, et al.
Publicado: (2017)

Immunogenicity of a Recombinant Mycobacterium smegmatis Vaccine Expressing the Fusion Protein CMX in Cattle from Goiás State, Brazil
por: ALVES DA SILVA, Duanne, et al.
Publicado: (2014)

The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients
por: Silva, Bruna Daniella Souza, et al.
Publicado: (2013)

The mc(2)-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects
por: de Oliveira, Fábio Muniz, et al.
Publicado: (2016)

Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2013)

Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2022)

Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection
por: de Sousa, Eduardo Martins, et al.
Publicado: (2012)

In Vitro Antimicrobial Susceptibility of Mycobacterium massiliense Recovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries
por: Cardoso, Alessandra Marques, et al.
Publicado: (2011)

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory
por: da Costa, Adeliane Castro, et al.
Publicado: (2014)

Correction: Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection
por: de Sousa, Eduardo Martins, et al.
Publicado: (2013)

The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis
por: Trentini, Monalisa M., et al.
Publicado: (2016)

The Activity of a Hexameric M17 Metallo-Aminopeptidase Is Associated With Survival of Mycobacterium tuberculosis
por: Correa, Andre F., et al.
Publicado: (2017)

Recombinant BCG expressing the LTAK63 adjuvant increased memory T cells and induced long-lasting protection against Mycobacterium tuberculosis challenge in mice
por: Marques-Neto, Lázaro Moreira, et al.
Publicado: (2023)

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
por: Enriquez, Ana B., et al.
Publicado: (2021)

Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis
por: Rabahi, Marcelo Fouad, et al.
Publicado: (2007)

Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis
por: da Costa, Adeliane C., et al.
Publicado: (2017)

Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against Mycobacterium massiliensis
por: Marques-Neto, Lázaro M., et al.
Publicado: (2018)

Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
por: Serra-Vidal, Mᵃdel Mar, et al.
Publicado: (2014)

Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice
por: Trentini, Monalisa Martins, et al.
Publicado: (2022)

A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
por: da Costa, Adeliane Castro, et al.
Publicado: (2014)

Paracoccidioides brasiliensis pancreatic destruction in Calomys callosus experimentally infected
por: Fortes, Rogério M, et al.
Publicado: (2009)

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020)

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
por: Nascimento, Ivan P., et al.
Publicado: (2017)

Decreased Expression of CD314 by NK Cells Correlates with Their Ability to Respond by Producing IFN-γ after BCG Moscow Vaccination and Is Associated with Distinct Early Immune Responses
por: da Costa, Adeliane Castro, et al.
Publicado: (2023)

Mycobacterium bovis PknG R242P Mutation Results in Structural Changes with Enhanced Virulence in the Mouse Model of Infection
por: de Oliveira, Fábio Muniz, et al.
Publicado: (2022)

Regulatory T Cells in Mycobacterium tuberculosis Infection
por: Cardona, Paula, et al.
Publicado: (2019)

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection
por: Liang, Yan, et al.
Publicado: (2023)

Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection
por: Tian, Maopeng, et al.
Publicado: (2018)

Mycobacterium abscessus subsp. massiliense mycma_0076 and mycma_0077 Genes Code for Ferritins That Are Modulated by Iron Concentration
por: Oliveira, Fábio M., et al.
Publicado: (2018)

Cytokine/chemokine profiles in people with recent infection by Mycobacterium tuberculosis
por: Herrera, Mariana, et al.
Publicado: (2023)

Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis
por: Nadeem, Sajid, et al.
Publicado: (2020)

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis
por: Zatarain-Barrón, Zyanya Lucia, et al.
Publicado: (2020)

Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit
por: Yadav, Jyoti, et al.
Publicado: (2023)

Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant Acinetobacter baumannii
por: das Neves, Rogério Coutinho, et al.
Publicado: (2019)

Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis
por: Sankar, Poornima, et al.
Publicado: (2023)

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
por: Ullah, Nadeem, et al.
Publicado: (2020)

The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection
por: Wei, Li, et al.
Publicado: (2021)

A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells
por: Yu, Qi, et al.
Publicado: (2017)

Immunological effects of the PE/PPE family proteins of Mycobacterium tuberculosis and related vaccines
por: Guo, Fangzheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2i3h8k4gi9c2a6op7g9vv2315